Article in Bioconjugate chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 2 institutions in 1 country.
Aryn A AlaniziDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.
Alexandre M SorlinDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-9589-6131
Matthew F L ParkerDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.
Marina López-ÁlvarezDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0001-5794-5951
Hecong QinDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.
Sang Hee LeeDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0001-8578-9968
Joseph BlechaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.
Oren S RosenbergDepartment of Medicine, University of California, San Francisco, San Francisco, California 94158, United States.
Joanne EngelDepartment of Medicine, University of California, San Francisco, San Francisco, California 94158, United States.
Michael A OhligerDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.
Robert R FlavellDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-8694-1199
David M WilsonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-1095-046X
University of California, San Francisco · USSan Francisco General Hospital · US
Funding
Development of 11C-PABA as a bacteria-specific imaging agent for spinal infectionsR01EB025985 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, SANJAY, WILSON, DAVID M · 2018 to 2021
$2.7M
Sensing living P. aeruginosa using D-alanine derived radiotracersR01EB030897 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ENGEL, JOANNE N., OHLIGER, MICHAEL · 2021 to 2024
$2.7M
Clinical translation of D-amino acid derived PET tracers for imaging spinalinfectionR01EB024014 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OHLIGER, MICHAEL, WILSON, DAVID M · 2017 to 2020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bioorthogonal Radiolabeling of Azide-Modified Bacteria Using [ · full record | OpenQuestion